-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Trial Designs for Decentralized Clinical Trials

Symposia: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation Program: Scientific Workshops
Friday, December 6, 2024: 2:05 PM-2:52 PM
Room 4 (San Diego Convention Center)
Moderator:
and Jean M Connors, MD, Brigham and Women's Hospital
Disclosures:
Connors: Abbott: Honoraria; Anthos: Honoraria; Bristol Myers Sqibb: Honoraria; Bayer: Honoraria; Janssen: Honoraria; Pfizer: Honoraria; Sanofi: Honoraria; Werfen: Honoraria; Perosphere: Honoraria.
Discuss the various trial designs for decentralized clinical trials, challenges for implementation of these trial designs and the regulatory questions that may arise with these trial designs.
Moderator Introduction

Jean M Connors, MD

Harvard Medical School, Brigham and Women's Hospital, Boston, MA
Are We Ready for Innovative Decentralized Clinical Trials in Hematology? Learnings from the COVID19 Pandemic

Jean M Connors, MD

Harvard Medical School, Brigham and Women's Hospital, Boston, MA
How Can AI Help in 'real World' Patient Selection?

Andrew Srisuwananukorn, MD

The Ohio State University, Columbus, OH
Using Wearables for Patient Monitoring in Decentralized Clinical Trials- Ready for Prime Time?

Shirley D'Sa, MD(Res)

University College London Hospitals NHS Foundation Trust, London, United Kingdom
Panel Discussion
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
<< Previous Session | Next Session >>